Translating knowledge

IOCBTech is a technology transfer office and subsidiary company of IOCB (the Institute of Organic Chemistry and Biochemistry CAS). The company matches results of basic research done at the IOCB with needs of commercial partners to ultimately bring new ideas in medicinal chemistry, material sciences, and other fields of chemistry to human use.

Oxytocin

OXYTOCINTM

1958
Remestyp

TERLIPRESINTM

1965
Dermazulen

DERMAZULENTM

1969
Minirin

DESMOPRESINTM

1970
Usal

USALTM

1975
Adiuretin

ADIURETINTM

1975
Duvira gel

DUVIRA GELTM

1980
Duratocin

DURATOCINTM

1985
Vistide

VISTIDETM

1996

VIREADTM

2001

HEPSERATM

2002

TRUVADATM

2004

ATRIPLATM

2006

COMPLERATM

2011

STRIBILDTM

2012

Projects & Opportunities

Here you can explore our projects which are available for co-development or licensings.

About IOCB Tech

The IOCB Tech team supports management and decision-making processes in Target Research Groups of IOCB e.g. by due diligence analyses, market potential studies, and project feasibility evaluation. Moreover, the company is responsible for networking and industry partner search or negotiations of contracts and agreements in the field of intellectual property.

An integral part of IOCB Tech’s duties is the organization and development of spin-off companies on IOCB’s technology platform.

IOCB Team

News

10/09
2019

UCT and IOCB Prague establish special research chair

10/09/2019
At the University of Chemistry and Technology Prague (UCT), a prestigious new position called Chair – Medicinal Chemistry is being established for a leading foreign expert in drug discovery and development. It offers an unconventional form of collaboration with the Institute of Organic Chemistry and Biochemistry of the Czech…
07/31
2019

Prague-Weizmann Summer School on Drug Discovery 2019

07/31/2019
Prague, Czech Republic, September 2nd – 6th, 2019 Advances in drug discovery process From the basic science up to production process and development We are proud to announce that IOCB Tech is a co-organizer of the 6th year of the Prague-Weizmann Summer School on Drug Discovery 2019. The Summer…
05/16
2019

SHINE and IOCB Prague Enter Lu-177 Process License Agreement

05/16/2019
Novel Separation Method Accelerates SHINE’s Path to Market for Cancer Treatment Isotopes May 15th, 2019Prague, Czechia – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, and the Institute of Organic Chemistry and Biochemistry of the…
05/28
2018

Winter school in DRUG DISCOVERY – Prague-Weizmann Winter School

05/28/2018
5th year of the Prague Summer School now Prague-Weizmann Winter School ADVANCES IN DRUG DISCOVERY NOVEL APPROACHES IN DRUG DESIGN AND DEVELOPMENT Rehovot, Israel, Dec 3rd – Dec 7th 2018   Following four successful years of the Prague Summer School on Advances in Drug Discovery, this year the…
05/28
2018

IOCB Tech at BioInternational in Boston

05/28/2018
IOCB Tech will be at the 25th anniversary of BioInternational in Boston. We are part of the BioMedChemCluster and can be found at Booth 1908a. Please take a look at the BioInternational event here.    …
02/23
2018

IOCB Tech at BioVaria 2018

02/23/2018
IOCB Tech is again one of the partners at the BioVaria conference. The event will take place April 23-24, 2018, in Munich, Germany BioVaria brings together European research institutions across national borders in order to improve the transfer of their research results into application. In…
01/11
2018

Featured Projects

01/11/2018
Three featured projects with self-explanatory videos. Please follow the link and like always if you would like to learn more about the projects and/or IOCB-TTO please don’t hesitate to contact us via email or phone. DIANA iBodies www.ibodies.eu rapid DNA staining…
11/11
2016

Lipeon pitch at BioVaria 2016

11/11/2016
If you are interested in the Lipeon Therapeutics project developed at the IOCB Prag, you can find Martin Fusek’s 5 minutes spin-off panel pitch at BioVaria 2016 here. For more information contact our IOCBTech team info@iocbtech.cz.
08/11
2016

Successful Basel Life Science Week

08/11/2016
Successful Basel Life-Science Week for IOCBTech, two oral presentations, two poster presentation and one 3rd poster price IOCB was successfully presenting four technologies at Basel Life Science Week September 19-22. Eva Kudova presented her work on “S.M.A.R.T. Steroids – NMDA Receptors Modulators Acting As CNS Therapeutics” and Vaclav Navratil his…
07/29
2016

New granted US patent

07/29/2016
LIPOPOLYAMINES OF SPERMINE TYPE FOR CONSTRUCTION OF LIPOSOMAL TRANSFECTION SYSTEMS Lukas Drasar and Miroslav Ledvina, from the  Institute of Organic Chemistry and Biochemistry (IOCB), invented in collaboration with Zina Korvasova and Jaroslav Turanek from the Faculty of Veterinary Medicine of the University of Veterinary and Pharmaceutical Science Brno, …
06/01
2016

Awarded US patent

06/01/2016
HELQUAT DERIVATIVES, PREPARATION THEREOF, AND USE THEREOF AS MEDICAMENTS Congratulations to  Filip Teply and Mirek Hajek, the patent application for there development of  “Helquat derviates” was granted in The United States. For more information about the patent please follow it on Espacenet. For more detail information on the…
04/29
2016

Patent awarded

04/29/2016
LIPIDATED PEPTIDES AS ANTI-OBESITY AGENTS Congratulations to  Lenka Maletinska, Blanka Zelezna, Miroslava Blechova and Andrea Spolcova, the patent application for their discovery on “Lipidated peptides as anti-obesity agent” was granted in Australia. For more information on the patent follow the link Espacenet . For more information on the…
03/04
2016

Where to meet IOCBTech in 2016

03/04/2016
A list of events IOCBTech members will attend and be happy to meet investors and scientists If you would like to meet and discuss our projects in person, you have two possibilities. First contact us via info@iocbtech.cz or by phone +420 220 612 258 to set up a…
03/01
2016

IOCB at 1st BioSpot Conference

03/01/2016
IOCB projects have been successfully presented at the 1st BioSpot conference in Prague last Wednesday, February 24th, 2016. Biospot is a new platform where Czech bio-research will meet investors and industry partners from the Czech Republic and the region. The purpose is to connect researchers, their ideas and their inventions…
02/22
2016

IOCB projects selected for presentation at BioSpot 2016

02/22/2016
IOCB’s iBodies project got selected for oral presentation at the 1st annual BioSpot Conference in Prague, February 24th 2016 at the DOX gallery. Biospot is a new platform where Czech bio-researcher will have the chance to meet investors and industry representatives from the Czech Republic and around. The…

Where to meet us?

Visit of Scandinavia

When: 12/08/2019 – 16/08/2019
Where: Finland/Jyväskylä & Norway/Trodheim

Description:

The main topics of the visit are the transfer of knowledge and technology – commercialization, business development, the motivation of scientists, rules for a spin-off, processing of research and development results, organization of technology transfer, etc. We would also discuss the possibilities of cooperation between the institutions. University of Jyväskylä,…

Bio Europe Spring 2019

When: 24/03/2019 – 27/03/2019
Where: Vienna, Austria (map)

Description:

You can follow IOCBTech via Twitter with the Hashtag #IOCBTech…

Bio US

When: 04/06/2018 – 07/06/2018
Where: Boston, Massachusetts, USA (map)